Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

Clinical trial NCT05256641 · RECRUITING

Trial details

NCT number: NCT05256641
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma High-grade B-cell Lymphoma Transformed Lymphoma Secondary Central Nervous System Lymphoma

Start date: 2023-01-23
Primary completion: 2027-01-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.